• Heymann D, Rédini F. Targeted therapies for bone sarcomas. BoneKey Reports sous presse


  •  Bussone G, Tamby MC, Calzas C, Kherbeck N, Sahbatou Y, Sanson C, Ghazal K, Dib H, Weksler BB, Broussard C, Verrecchia F, Yaici A, Witko-Sarsat V, Simonneau G, Guillevin L, Humbert M, Mouthon L. IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction. Ann Rheum Dis. 2012;71:596-605.
  • Berthelot JM, De Bandt M, Morel J, Benatig F, Constantin A, Gaudin P, Le Loet X, Maillefert JF, Meyer O, Pham T, Saraux A, Solau-Gervais E, Spitz E, Wendling D, Fautrel B, Guillemin F, STPR group of French Society of Rheumatology;A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: the 'FLARE' instrument. Ann Rheum Dis. 2012;71:1110-6.
  • Cassier PA, Fumagalli E, Rutkowski P, Schöffski P, Van Glabbeke M, Debiec-Rychter M, Emile JF, Duffaud F, Martin-Broto J, Landi B, Adenis A, Bertucci F, Bompas E, Bouché O, Leyvraz S, Judson I, Verweij J, Casali P, BlayJY, Hohenberger P; European Organisation for Research and Treatment of Cancer. Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumours in the tyrosine kinase inhibitor era. Clin Cancer Res. 2012; 15;18:4458-64.
  • Guihard P, Danger Y, Brounais B, David E, Brion R, Delecrin J, Richards CD, Chevalier S, Rédini F, Heymann D, Gascan H, Blanchard F. Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling. Stem Cells. 2012;30:762-72.
  • Minard-Colin V, Ichante JL, Nguyen L, Paci A, Orbach D, Bergeron C, Defachelles AS, André N, Corradini N, Schmitt C, Tabone MD, Blouin P, Sirvent N, Goma G, Geoerger B, Oberlin O. Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma - A report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE). Eur J Cancer. 2012; 48:2409-16.
  • Geoerger B, Estlin EJ, Aerts I, Kearns P, Gibson B, Corradini N, Doz F, Lardelli P, Miguel BD, Soto A, Prados R, Vassal G. A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) study. Eur J Cancer. 2012; 48:289-96.
  • Trichet V, Layrolle P, Escriou V. Lipid nanoparticles for siRNA delivery in lungs. Nanomedicine (Lond). 2012 Feb;7:181-3.
  • Lavenus S, Trichet V, Le Chevalier S, Hoornaert A, Louarn G, Layrolle P. Cell differentiation and osseointegration influenced by nanoscale anodized titanium surfaces. Nanomedicine. 2012;7:967-8.
  • Hess E, Duheron V, Decossas M, Lézot F, Berdal A, Chea S, Golub R, Bosisio MR, Bridal SL, Choi Y, Yagita H, Mueller CG.RANKL induces organised lymph node growth by stromal cell proliferation. JImmunol.2012;188:1245-54.
  • Pautier P, Floquet A, Penel N, Piperno-Neumann S, Isambert N, Rey A, Bompas E, Cioffi A, Delcambre C, Cupissol D, Collin F, Blay JY, Jimenez M, Duffaud F. Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer(FNCLCC) French Sarcoma Group Study (TAXOGEM study). Oncologist. 2012;17:1213-20.
  • Ray-Coquard I, Italiano A, Bompas E, Le Cesne A, Robin YM, Chevreau C, Bay JO, Bousquet G, Piperno-Neumann S, Isambert N, Lemaitre L, Fournier C, Gauthier E, Collard O, Cupissol D, Clisant S, Blay JY, Penel N; French Sarcoma Group (GSF/GETO). Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO). Oncologist. 2012; 17:260-6.
  •  David E, Tirode F, Baud'Huin M, Guihard P, Laud K, Delattre O, Heymann MF, Heymann D, Rédini F, Blanchard F. Oncostatin M Is a Growth Factor for Ewing Sarcoma. Am J Pathol.2012;181:1782-95.
  • Picarda G, Surget S, Guiho R, Télétchéa S, Berreur M, Tirode F, Pellat-Deceunynck C, Heymann D, Trichet V, Rédini F. A functional, new short isoform of Death Receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanisms. Mol Cancer Res. 2012;10:336-46.
  • Delaplace M, Lhommet C, De Pinieux G, Vergier B, de Muret A, Machet L. Primary cutaneous Ewing sarcoma: a systematic review focused on treatment and outcome. Br J Dermatol.2012;166:721-6.
  • Picarda G, Trichet V, Télétchéa S, Heymann D, Rédini F.TRAIL receptor signaling and therapeutic option in bone tumours: the trap of the bone microenvironment. Am J CancerRes. 2012;45-64.
  • Italiano A, Cioffi A, Coco P, Maki RG, Schöffski P, Rutkowski P, Le Cesne A, Duffaud F, Adenis A, Isambert N, Bompas E, Blay JY, Casali P, Keohan ML, Toulmonde M, Antonescu CR, Debiec-Rychter M, Coindre JM, Bui B. Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumours (GIST) refractory to first-line imatinib and second-line sunitinib. Ann Surg Oncol. 2012; 19:1551-9.
  • Vuillaumier-Barrot S, Isidor B, Dupré T, Le Bizec C, David A, Seta N. Expanding the Spectrum of PMM2-CDG Phenotype. JIMD Rep. 2012;5:123-5.
  • Pichard V, Aubert D, Boni S, Battaglia S, Ivacik D, Nguyen TH, Arbuthnot P, Ferry N. Specific micro RNA-regulated TetR-KRAB transcriptional control of transgene expression in viral vector-transduced cells. PLoS One. 2012; 7 :e51952.
  • Guyader C, Céraline J, Gravier E, Morin A, Michel S, Erdmann E, de Pinieux G, Cabon F, Bergerat JP, Poupon MF, Oudard S. Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced bytyrosine kinase inhibitors. PLoS One 2012;7:e42252.
  • Brullé L, Vandamme M, Riès D, Martel E, Robert E, Lerondel S, Trichet V,  Richard S, Pouvesle JM, Le Pape A. Effects of a Non Thermal Plasma Treatment Alone or in Combination with Gemcitabine in a MIA PaCa2-luc Orthotopic Pancreatic Carcinoma Model. PLoS One. 2012;7:e52653.
  • Bouacida A, Rosset P, Trichet V, Guilloton F, Espagnolle N, Cordonier T, Heymann D, Layrolle P, Sensébé L, Deschaseaux F. Pericyte-like progenitors show high immaturity and engraftment potential as compared with mesenchymal stem cells. PLoS One.2012;7:e48648.
  • Guillard C, Lintz F, Odri GA, Vogeli D, Colin F, Collon S, Chappard D, Gouin F, Robert H. Effects of graft pretensioning in anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 2012; 20:2208-13.

suite 2012

  • Peyrode C, Weber V, David E, Vidal A, Auzeloux P, Communal Y, Dauplat MM, Besse S, Gouin F, Heymann D, Chezal JM, Rédini F, Miot-Noirault E. Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies. Invest New Drugs. 2012; 30:178-90.
  • Lopes R, Philippeau JM, Passuti N, Gouin F. High rate of ceramic sandwich iner fracture. Clin Orthop Relat Res. 2012;470:1705-10.
  • Kovar H, Alonso J, Aman P, Aryee DN, Ban J, Burchill SA, Burdach S, De Alava E, Delattre O, Dirksen U, Fourtouna A, Fulda S, Helman LJ, Herrero-Martin D, Hogendoorn PC, Kontny U, Lawlor ER, Lessnick SL, Llombart-Bosch A, Metzler M, Moriggl R, Niedan S, Potratz J, Rédini F, Richter GH, Riedmann LT, Rossig C, Schäfer BW, Schwentner R, Scotlandi K, Sorensen PH, Staege MS, Tirode F, Toretsky J, Ventura S, Eggert A, Ladenstein R. The first European interdisciplinary ewing sarcoma research summit. Front Oncol. 2012;2:54.
  • Heymann MF, Herisson F, Davaine JM, Charrier C, Battaglia S, Passuti N, Lambert G, Gouëffic Y, Heymann D. Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: Comparison between carotid and femoral beds. Cytokine. 2012;58:300-6. review
  • Couec ML, André N, Thebaud E, Minckes O, Rialland X, Corradini N, Aerts I, Bérard PM, Bourdeaut F, Leblond P; on the behalf of the Comité Pharmacologie of the SFCE. Bevacizumab and irinotecan in children with recurrent or refractory brain tumours: Toxicity and efficacy trends. Pediatr Blood Cancer. 2012; 15;59:34-8.
  • Schmitt F, Caldari D, Corradini N, Gicquel P, Lutz P, Leclair MD, Podevin G. Tolerance and efficacy of preventive gastrostomy feeding in pediatric oncology. Pediatr Blood Cancer.2012; 59:874-80.
  • Bertoncini P, Le Chevalier S, Lavenus S, Layrolle P, Louarn G. Early adhesion of human mesenchymal stem cells on TiO(2) surfaces studied by single-cell force spectroscopy measurements. J Mol Recognit. 2012;25:262-9.
  • Bienvenu T, Diebold B, Chelly J, Isidor B. Refining the phenotype associated with MEF2C point mutations. Neurogenetics. 2013;14:71-5.
  • Isidor B, Poignant S, Picherot G, Mégabarné A, Quartier P, Bader-Meunier B, Le Caignec C, Le Merrer M, Baujat G, Cormier-Daire V, David A. Progressive polyepiphyseal dysplasia with arthropathy: a distinct disorder from idiopathic juvenile arthritis and pseudorheumatoid dysplasia? Am J Med Genet A. 2012;158A:1754-8.
  • Isidor B, Villa O, Pichon O, Briand A, Poulain D, Boisseau P, Pérez-Jurado LA, Le Caignec C. De novo duplication and deletions at 7q in a three-generation family. Am J Med Genet A. 2012;158A:1493-7.
  • Strullu M, Rialland F, Cahu X, Brissot E, Corradini N, Thomas C, Blin N, Rialland X, Méchinaud F, Mohty M. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience. Eur J Haematol. 2012; 88:504-9.
  • Miot-Noirault E, Gouin F, Dauplat MM, Heymann D, Chezal JM, Rédini F. Relevance of the POS-1 Orthotopic Model As An "Imaging Model" for In Vivo and Simultaneous Monitoring of Tumour Proliferation and Bone Remodeling in Osteosarcoma. Cancer Biother Radiopharm. 2012;27:96-103.
  • Eugene T, Corradini N, Carlier T, Dupas B, Leux C, Bodet-Milin C. F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas. Nucl Med Commun. 2012; 33:1089-95.
  • Atean I, Pointreau Y, Rosset P, Garaud P, De-Pinieux G, Calais G. Prognostic factors of extremity soft tissue sarcoma in adults. A single institution alanalysis. Cancer Radiother. 2012;16:661-6.
  • Lintz F, Moreau A, Odri GA, Waast D, Maillard O, Gouin F. Critical study of resection margins in adult soft-tissue sarcoma surgery. Orthop Traumatol Surg Res. 2012;98:S9-S18
  • Bouguennec N, Gouin F, Piétu G. Isolated anterior unilateral sacroiliac dislocation without pubic arch disjunction. Orthop Traumatol Surg Res. 2012;98:359-62.
  • Colin F, Lintz F, Bargoin K, Guillard C, Venet G, Tesson A, Gouin F. Aseptic arthritis after ACL reconstruction by Tape Locking Screw (TLS®): report of two cases. Orthop Traumatol Surg Res.2012;98:363-5.
  • Baraut J, Farge D, Jean-Louis F, Kesmandt H, Durant C, Verrecchia F, Michel L. [Cytokines in systemic sclerosis]. Pathol Biol (Paris). 2012;60:127-39.
  • Lejus C, Desdoits A, Lambert C, Langlois C, Roquilly A, Gouin F, Asehnoune K. Preoperative moderate renal impairment is an independent risk factor of transfusion in elderly patients undergoing hip fracture surgery and receiving glow-molecular-weight heparin for thromboprophylaxis. J Clin Anesth. 2012; 24:378-84.
  • Demoor-Goldschmidt C, Minard-Colin V, Cassagneau E, Supiot S, Oberlin O, D'hautuille C, Corradini N. Ameloblastic Fibrosarcoma of the Mandible: Report of 2 Chemosensitive Pediatric Cases.J Pediatr Hematol Oncol. 2012; 34:72-6.
  • Geffroy L, Hamel O, Odri GA, Guillard S, Passuti N, Gouin F, Rogez JM, Hamel A. Treatment of an aneurysmal bone cyst of the lumbar spine in children and teenagers, about five cases. J Pediatr Orthop B. 2012;21:269-75.
  • Cormier B, Arbion F, Rousselot C, Gaillardin L, de Pinieux G. About a case of rhabdomyosarcoma with an aberrant expression of epithelial markers: a cause ofmisdiagnosis. Ann Pathol. 2012;32:224-8.
  • Illac C, Delisle MB, Bonnevialle P, Chiavassa-Gandois H, de Pinieux G, Gomez-Brouchet A. Telangiectatic osteosarcoma secondary to a liposclerosingmyxofibrous tumour: a case report. Ann Pathol.2012;32:259-62.
  • Gaspar N, Di Giannatale A, Geoerger B, Rédini F, Corradini N, Enz-Werle N, Tirode F, Marec-Berard P, Gentet JC, Laurence V, Piperno-Neumann S, Oberlin O, Brugieres L. Bone sarcomas: from biology to targeted therapies. Sarcoma. 2012;2012:301975 review
  • Duffaud F, Even C, Ray-Coquard I, Bompas E, Khoa-Huynh T, Salas S, Cassier P, Dufresne A, Bonvalot S, Ducimetiere F, Le Cesne A, Blay JY. Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients. Clin Sarcoma Res. 2012; 5;2:11
  • Talbot J, Verrecchia F.[Gap junctions and bone remodeling].Biol Aujourdhui. 2012;206:125-34.

Publications 2010- 2011-2009


Publications  2008 - 2000